SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-046937
Filing Date
2024-04-23
Accepted
2024-04-23 16:28:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A srzn_2024_defa_14a.htm DEFA14A 22387
2 GRAPHIC img209981390_0.jpg GRAPHIC 141889
3 GRAPHIC img209981390_1.jpg GRAPHIC 93569
  Complete submission text file 0000950170-24-046937.txt   348033
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39635 | Film No.: 24865163
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)